Please login to the form below

From ideals to execution – exploring the realities of patient-centricity

The Ashfield Patients & Pharma Future Forum explores the reality of patient-centricity in 2016 and what’s next for pharma.

Since eyeforpharma, Barcelona 2015, we have heard industry, vendors, specialists, advocacy groups and patients talking about patient-centricity: what is it? What does it mean for the industry and the wider healthcare environment? What does it mean for patients? What will it look like in the future?  

However, one question that’s been missing recently is “Why does it matter?” The reason this question is no longer prominent is that we have moved past the phase where we are looking for a rationale to drive towards a more patient-centric industry, and we are now actually trying to shape, deliver and measure it.  

We wanted to understand how the industry was moving from vision to reality in patient-centricity. What we wanted to understand was the reality of patient-centricity today, the truth behind the buzzwords and challenges in delivering this vision. Who better to ask than industry representatives?  

We convened a panel of 12 representatives from pharmaceutical companies, including large broad portfolio companies as well as smaller/mid-sized more specialist providers, in a mix of patient-centred roles from Chief Patient Officer through to regional and functional patient leads. We ran a 2-week online expert panel earlier this year, inviting our panel to discuss, as openly as possible, their company vision, the strategy and structure that they were putting in place for delivering the vision, and the key challenges they had found in moving towards patient-centricity. The panel was moderated by Andrew Schorr of Patient Power, along with Ashfield Healthcare Communications.  

Click here to download our “From ideals to execution” whitepaper
 to learn more about the insights shared during our Patients & Pharma Future Forum and what’s next for pharma.

7th July 2016



Company Details


Contact Website

Ashfield House
Resolution Road
Ashby de la Zouch
LE65 1HW

Latest content on this profile

‘Delivering healthcare events with certainty and impact’
Ashfield Meetings & Events launches new website
The Ashfield Solution - Accelerate product uptake and maximize ROI
A pioneering multichannel optimization model powered by advanced analytics with the ability to flex resources based on real time results.
Patient Engagement and Experience Conference, 16-17 May
Ashfield and S3 Connected Health, Silver Sponsors at the 3rd Annual Patient Engagement and Experience Conference in Amsterdam on 16-17 May, will be speaking on how digitally enhanced Patient Support Programmes can extend the continuity and relevance of care into patients’ everyday lives.
Ashfield will be exhibiting at ISMPP US
On 30 April - 2 May 2018, Ashfield Healthcare Communications will be exhibiting at the 14th Annual Meeting of ISMPP at the Gaylord National Resort & Convention Center, National Harbor, MD.
Putting the patient first
You’ve invested millions in the development of your new drug or therapy and have successfully completed clinical trials - now you are ready to launch. Data has been collected, efficacy is understood and side effects are recorded. But an important question remains: is your target patient population prepared?
Ashfield joins the eyeforpharma webinar: The PSP Masterclass
Nagore Fernandez, Ashfield’s Head of Patient Services for EUCAN and Anna Baker, a Consultant in Health Psychology working closely with Ashfield, are joining an eyeforpharma panel debate: 'How Health Psychology drives winning Patient Support Programmes'. The webinar will take place Thursday 26th April at 9am New York, 2pm UK and 3pm Paris time.